Correction to: Nature Communications https://doi.org/10.1038/s41467-023-38605-3, published online 19 May 2023
In the version of the article initially published, there were errors in Fig. 6d, Supplementary Figs. 6d and 10b, and the associated Source data.
In Fig. 6d, the image for Gzmb IHC staining following Trametinib treatment was inadvertently duplicated from the corresponding image following Combination treatment. The correct version of this figure has been added to the original article.
In Supplementary Fig. 6d, the western blot showing USP5 in the “IP: PD-1” group was inadvertently duplicated from Supplementary Fig. 6c. The correct version of this figure is now provided online in the updated Supplementary information.
The Source data for Supplementary Fig. 10b was inadvertently duplicated from Supplementary Fig. 10a. We have now provided the corrected dataset, and the corrected Supplementary Fig. 10b is now provided online in the updated Supplementary information.
The corrected Supplementary information and Source data are available alongside the original article. The Supplementary information accompanying this amendment contains the original, incorrect figures for comparison.
Author information
Authors and Affiliations
Corresponding authors
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xiao, X., Shi, J., He, C. et al. Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nat Commun 16, 5357 (2025). https://doi.org/10.1038/s41467-025-61049-w
Published:
DOI: https://doi.org/10.1038/s41467-025-61049-w
